story of the week
Cardiovascular Prevention With Glucose-Lowering Drugs in Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cardiovascular prevention with glucose-lowering drugs in type 2 diabetes: An evidence-based approach to the categories of primary and secondary prevention
Diabetes Obes Metab 2023 Aug 02;[EPub Ahead of Print], E Mannucci, GA SilveriiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.